Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
Clinical trial NCT04988386 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04988386
- Sponsor
- Eidos Therapeutics, a BridgeBio company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-27
- Primary completion
- 2028-04-15
- Enrollment
- 389
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.